USPTO serial 79216752
GP PHARM
Reviewed by CopyMark Law Group
Reg. 5435660Status 706Registered
- Filing date
- Status date
- Registration date
- Apr 3, 2018
- Examiner
- DINALLO, KEVIN M
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with GP PHARM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Barcelona, ES
Barcelona, ES
Barcelona, ES
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth Lee D'Amore
Elizabeth Lee D'Amore Lucas & Mercanti, LLP100 S. Jefferson Road, Suite 202Whippany, NJ 07981United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in the cosmetic and pharmaceutical industries for human use | ACTIVE | — |
| 005 | House mark for pharmaceutical preparations other than veterinary preparations; [ Sanitary products for medical purposes, namely, sterilizing preparations and antibacterial preparations; Dietetic substances for medical use, namely, dietetic foods adapted for medical use; Food for babies; Medical plasters, being material for dressings, namely, medical dressings, bandages, gauzes, adhesive bands, tapes; Material for dental fillings and dental impressions; Disinfectants; herbicides; ] pharmaceutical preparations and substances for use in urology, oncology and gynecology | ACTIVE | — |
| 042 | Scientific and technological services, as well as research and design services relating thereto, namely, scientific research for medical purposes in the field of urology, oncology, gynecology, cardiology, neurology, gastroenterology, endocrinology, immunology, rheumatology, ophthalmology, biotechnology, anti-cancer treatments, chemotherapy, hormonal therapies, treatment of pain and inflammation, treatment of muscular disorders, treatment of metabolic disorders and active peptides for medical use; Pharmaceutical research services; Biological research and medical research; Clinical research in the field of urology, oncology, gynecology, cardiology, neurology, gastroenterology, endocrinology, immunology, rheumatology, ophthalmology, biotechnology, chemotherapy, hormonal therapies, analgesia, anti-inflammatory compounds, muscular disorders, metabolic disorders and active peptides for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GP Pharm S.A.
- Other trademarks owned by GP Pharm S.A.
- Other trademarks owned by GP Pharm S.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named GP PHARM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 13, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 13, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 9, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 9, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 9, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 9, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 20, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 20, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Nov 20, 2024 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Nov 18, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 27, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Apr 3, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 6, 2019 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 18, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 29, 2018 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Aug 11, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 14, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 14, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 3, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 3, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 3, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 16, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 16, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 27, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 27, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 27, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 9, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 9, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 9, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 9, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 9, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 21, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Nov 8, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 8, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 8, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 8, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 8, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 3, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 3, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 1, 2017 | ALIE | ASSIGNED TO LIE | — |
| Oct 23, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 21, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 29, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 28, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 26, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 26, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 25, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 21, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |